Cylene Pharmaceuticals San Diego, CA - 92121

Cylene Pharmaceuticals is categorized under Commercial Medical Research in San Diego, CA and active since 1997.

Cylene Pharmaceuticals was established in 1997, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417114 by the NAICS.

If you are seeking more information, feel free to contact William Rice, Chief Executive Officer at the company’s single location by writing to 5935 Cornerstone Court West # 100, San Diego, California CA 92121 or by phoning (858) 875-5100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cylene Pharmaceuticals
Contact Person: William Rice, Chief Executive Officer
Address: 5935 Cornerstone Court West # 100, San Diego, California 92121
Phone Number: (858) 875-5100
Annual Revenue (USD): Unknown
Founded: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 5417114
Share This Business:

Cylene Pharmaceuticals was started in 1997 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact William Rice, Chief Executive Officer for inquiries that concern Cylene Pharmaceuticals by calling the company number (858) 875-5100, as your correspondence is most welcome. Additionally, the physical location of the single location of Cylene Pharmaceuticals can be found at the coordinates 32.89549,-117.19087 as well as the street address 5935 Cornerstone Court West # 100 in San Diego, California 92121.

For its online presence, you may visit Cylene Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.